IN RE CIPRO CASES I & II

Respondents, Barr Laboratories, Inc., Watson Pharmaceuticals, Inc., Hoechst Marion Roussel, Inc., and The Rugby Group, Inc., Reply to Supplemental Brief

Cal.Feb 14, 2014